Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer

Published:2011-02-23 Issue:6 Volume:103 Page:470-477
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Phipps A. I.,Chlebowski R. T.,Prentice R.,McTiernan A.,Wactawski-Wende J.,Kuller L. H.,Adams-Campbell L. L.,Lane D.,Stefanick M. L.,Vitolins M.,Kabat G. C.,Rohan T. E.,Li C. I.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/103/6/470/7903999/djr030.pdf

Reference32 articles.

1. Molecular portraits of human breast tumours

2. Repeated observation of breast tumor subtypes in independent gene expression data sets

3. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

4. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

5. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study;Breast Cancer Research;2024-05-31

2. The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis;JNCI: Journal of the National Cancer Institute;2024-03-05

3. Relationship between early age at menarche, older age at menopause and subtypes of breast cancer: a scoping review;Revista Brasileira de Ginecologia e Obstetrícia;2024

4. Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers;BioMed Research International;2023-11-23

5. Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management;Breast Cancer: Targets and Therapy;2023-11